These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Rizatriptan: a new milestone in migraine treatment. Introduction. Ferrari MD Cephalalgia; 2000; 20 Suppl 1():1. PubMed ID: 11078002 [No Abstract] [Full Text] [Related]
6. [Rizatriptan-induced liver toxicity. Report of a case]. Fernandez-Atutxa A; Vergara M; Gil M; Dalmau B; Miquel M; Sanchez-Delgado J; Casas M Gastroenterol Hepatol; 2013 Apr; 36(4):261-3. PubMed ID: 23084593 [TBL] [Abstract][Full Text] [Related]
7. Effect of rizatriptan in the spectrum of headache. Allen C; Cady R; Lines C; McCarroll K Headache; 2001 Jun; 41(6):607-8. PubMed ID: 11437904 [No Abstract] [Full Text] [Related]
8. Improvement in migraine-specific quality of life in a clinical trial of rizatriptan. Santanello NC; Polis AB; Hartmaier SL; Kramer MS; Block GA; Silberstein SD Cephalalgia; 1997 Dec; 17(8):867-72; discussion 800. PubMed ID: 9453276 [TBL] [Abstract][Full Text] [Related]
9. Treatment of nonresponders to oral sumatriptan with zolmitriptan and rizatriptan: a comparative open trial. Mathew NT; Kailasam J; Gentry P; Chernyshev O Headache; 2000 Jun; 40(6):464-5. PubMed ID: 10849042 [TBL] [Abstract][Full Text] [Related]
10. Rizatriptan 5mg is not efficacious for migraine in adolescents. Maizels M Headache; 2002 Sep; 42(8):839-40; author reply 840. PubMed ID: 12390657 [No Abstract] [Full Text] [Related]
11. Efficacy and safety of rizatriptan versus standard care during long-term treatment for migraine. Rizatriptan Multicenter Study Groups. Block GA; Goldstein J; Polis A; Reines SA; Smith ME Headache; 1998; 38(10):764-71. PubMed ID: 11284464 [TBL] [Abstract][Full Text] [Related]
12. Rizatriptan wafer--sublingual vs. placebo at the onset of acute migraine. Allen C; Dayno J; Lines C; McCarroll K Cephalalgia; 2001 Feb; 21(1):77. PubMed ID: 11298669 [No Abstract] [Full Text] [Related]
13. Sum of Pain Intensity Differences (SPID) in migraine trials. A comment based on four rizatriptan trials. Tfelt-Hansen P; McCarroll K; Lines C Cephalalgia; 2002 Oct; 22(8):664-6. PubMed ID: 12383062 [TBL] [Abstract][Full Text] [Related]
14. Comparison of rizatriptan and other triptans on stringent measures of efficacy. Rieder MJ Neurology; 2002 Sep; 59(5):787; author reply 788. PubMed ID: 12229911 [No Abstract] [Full Text] [Related]
15. Comparison of rizatriptan 10 mg vs. zolmitriptan 2.5 mg in the acute treatment of migraine. Rizatriptan-Zolmitriptan Study Group. Pascual J; Vega P; Diener HC; Allen C; Vrijens F; Patel K Cephalalgia; 2000 Jun; 20(5):455-61. PubMed ID: 11037741 [TBL] [Abstract][Full Text] [Related]
16. Double-blind, placebo-controlled, dose-finding study of rizatriptan (MK-462) in the acute treatment of migraine. Gijsman H; Kramer MS; Sargent J; Tuchman M; Matzura-Wolfe D; Polis A; Teall J; Block G; Ferrari MD Cephalalgia; 1997 Oct; 17(6):647-51. PubMed ID: 9350384 [TBL] [Abstract][Full Text] [Related]
17. [Highly selective beginning. Associated symptoms and side effects in retrospect]. MMW Fortschr Med; 2003 May; 145 Suppl 2():107. PubMed ID: 14579499 [No Abstract] [Full Text] [Related]
18. New abortive agents for the treatment of migraine. Potrebic S; Raskin NH Adv Intern Med; 2001; 46():1-29. PubMed ID: 11147249 [No Abstract] [Full Text] [Related]